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survival in the neonatal hippocampus after
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Background: A considerable proportion of all newly generated cells in the hippocampus will die before
becoming fully differentiated, both under normal and pathological circumstances. The caspase-independent
apoptosis-inducing factor (AIF) has not been investigated previously in this context.
Results: Postnatal day 8 (P8) harlequin (Hq) mutant mice, expressing lower levels of AIF, and wild type
littermates were injected with BrdU once daily for two days to label newborn cells. On P10 mice were
subjected to hypoxia-ischemia (HI) and their brains were analyzed 4 h, 24 h or 4 weeks later. Overall tissue
loss was 63.5% lower in Hq mice 4 weeks after HI. Short-term survival (4 h and 24 h) of labeled cells in the
subgranular zone was neither affected by AIF downregulation, nor by HI. Long-term (4 weeks) survival of
undifferentiated, BLBP-positive stem cells was reduced by half after HI, but this was not changed by AIF
downregulation. Neurogenesis, however, as judged by BrdU/NeuN double labeling, was reduced by half after
HI in wild type mice but preserved in Hq mice, indicating that primarily neural progenitors and neurons were
protected. A wave of cell death started early after HI in the innermost layers of the granule cell layer (GCL)
and moved outward, such that 24 h after HI dying cells could be detected in the entire GCL.
Conclusions: These findings demonstrate that AIF downregulation provides not only long-term overall neuroprotection
after HI, but also protects neural progenitor cells, thereby rescuing hippocampal neurogenesis.
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Perinatal asphyxia-induced brain injury is one of the
most common causes of mortality and long term neuro-
logical impairment (cerebral palsy, mental retardation,
visual as well as hearing impairment, learning disability
and epilepsy) in term and preterm neonates [1]. A sig-
nificant breakthrough was that post-insult hypothermia
within 6 hours reduced severe disability, including cere-
bral palsy [2]. Other milestones in the field were the* Correspondence: changlian.zhu@neuro.gu.se
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reproduction in any medium, provided the orfindings that low dose rhEPO treatment [3] or delayed
hypothermia up to 10 hours [4] reduce the risk of dis-
ability in infants with moderate term hypoxic-ischemic
encephalopathy. Current therapeutic options for preterm
hypoxic-ischemic brain injury are limited and predomin-
antly supportive, to maintain physiological parameters.
Hypoxia-ischemia (HI) causes opposite reactions of in-
jury and repair. On the one hand, HI leads to neuronal, in-
cluding neural stem/progenitor cell (NSPC), death and
brain injury by excessive production of free radicals, exci-
tatory amino acids, inflammation as well as mitochondrial
dysfunction [1]. The patterns of neuronal cell death after
HI involve necrosis, apoptosis and autophagy, based on
biochemical and morphological criteria, and accumulating
data show that mixed morphological phenotypes often are
observed [5-9]. The immature brain retains its apoptotic. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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Figure 1 AIF down regulation reduced HI brain injury. A. The
study design. B. Representative MAP2 stainings from the levels of
dorsal hippocampus (left panels) and striatum (right panels) 4 weeks
post-HI of wild type (Wt) (upper panels) and Harlequin mutant (Hq)
mice (lower panels). C. The total tissue loss volume 4 weeks after HI
was reduced by 63.5% in Hq mice (n = 11) as compared with Wt
mice (n = 14). **P< 0.01.
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as judged by caspase-3 activation [10-13]. There are two
distinct pathways leading to nuclear apoptosis, caspase-
dependent and caspase-independent. Caspases are a class
of cysteine proteases that mediate apoptotic death in a var-
iety of cellular systems. Caspases are activated after HI,
particularly in the immature brain [12]. Consequently,
caspase inhibition affords neuroprotection in the imma-
ture brain [14,15]. Recent data demonstrate that when
caspase activation is inhibited at or downstream of the
apoptosome, neurons can undergo a delayed, caspase-
independent death [16]. One of the key components of
the caspase-independent cell death pathway is apop-
tosis-inducing factor (AIF) which, when released from
mitochondria, translocates to the nucleus and induces
large-scale DNA fragmentation and cell death [17]. In-
hibition or depletion of AIF can provide neuroprotec-
tion in vitro and in vivo [14,18,19]. HI also activates
protective and restorative mechanisms. For example, HI
up-regulates erythropoietin (EPO) and other growth/
trophic factors and induces NSPC proliferation and dif-
ferentiation [20]. Proliferating cells migrate to the injury
[21-23], even very long after the insult [24,25], inspiring
hope for tissue repair and plasticity. However, a related
problem is the poor survival of the newly generated
NSPCs after ischemic insults [26]. More than 90% of
newborn cells die within one month [27]. Therefore, ex-
ploring death mechanisms of endogenous NSPCs will
provide important information for prevention/inhibition
of NSPC death and hopefully promote brain repair. The
purpose of this study was to evaluate the effects of AIF
downregulation on neuronal and NSPC death after HI
in the immature brain as well as long-term effects on
brain injury.
Results
AIF downregulation reduced HI brain injury
Brain injury was evaluated on P38, 4 weeks after HI
(Figure 1A). The injury encompasses the cortex, hippo-
campus, striatum and thalamus (Figure 1B). The overall
tissue loss, including infarction and subsequent atrophy,
was 21.3± 5.6 mm3 (n=14) in Wt mice and 7.8± 2.2 mm3
(n=11) in Hq mutant mice, which corresponds to a 63.5%
reduction (P=0.002) (Figure 1C).
AIF downregulation had no effect on short-term
proliferation and survival
Cell proliferation in the subgranular zone (SGZ) was
assessed 4 h and 24 h after HI by BrdU labeling 1 and
2 days before HI (Figure 1A). This means that the labeled
cells were born 1 or 2 days before HI and survived at least
until 4 h or 24 h after HI. Neither the HI insult nor the Hq
mutation had any obvious short-term effect on the number
of BrdU-labeled cells in the SGZ (Figure 2A, 2B).AIF downregulation increased neuronal progenitor, but
not stem cell, survival
Cells in the SGZ expressing brain lipid binding protein
(BLBP) are undifferentiated, radial glia-like neural precur-
sors [28]. The number of BLBP-labeled cells in the SGZ
was not different between Wt and Hq mice, neither in con-
trol brains, nor after hypoxia-ischemia (Figure 3A, 3B). The
total number of surviving BrdU-labeled cells per GCL in
the control was 5359±456 in Wt (n=5) and 6210±541 in






































Figure 2 Cell proliferation in the DG after HI. A. Representative
microphotographs of BrdU stainings in the DG in naïve controls (top
panels), at 4 h (left panels) and 24 h (right panels) after HI. B. The bar
graph shows quantification of the total number of BrdU-positive cells in
the SGZ in controls (Cont) and ipsilateral hemisphere after HI in Wt and
Hq mice 4 h (n=5 or 8 for Wt and Hq controls, n=6 or 7 for Wt and Hq
HI) and 24 h (n =6 or 8 Wt and Hq controls, n= 7 or 8 for Wt and Hq HI).
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in Hq than Wt brains (p=0.030). In Wt mice, the number
decreased 40.1%, to 3209±605 (p=0.013), whereas in Hq
mice the decrease was only 17.6%, to 5115±532 (n.s.)
(Figure 3C, 3D). The phenotyping of newly generated cells
surviving 4 weeks showed that about 70% developed into
neurons, as judged by BrdU/NeuN double labeling
(Figure 3E, 3F), and this ratio was the same in Wt and Hq
animals, both in non-ischemic control and HI brains. Im-
portantly, while the number of labeled cells surviving
4 weeks after HI and differentiating into neurons decreased
approximately 45% in Wt mice, it was not significantlydecreased in Hq mice (Figure 3F). The number of newly
generated astrocytes, as indicated by BrdU/S100 double la-
beling was not different, neither between genotypes, nor
between control and HI mice (data not shown).
AIF downregulation reduced cell death in the dentate gyrus
Cell death in the hippocampus was investigated by
detecting DNA strand breaks (TUNEL), necrosis
(FBDP), as well as caspase-dependent (active caspase-3)
and -independent (nuclear AIF) apoptosis [12]. The
number of positive cells was counted in the GCL+ SGZ
4 h and 24 h after HI (Figure 4). Interestingly, early after
HI (4 h) dying cells, as judged by TUNEL, active cas-
pase-3 and nuclear AIF, were mainly detected in the
inner layers of the GCL, whereas later (24 h) after the
insult dying cells could be detected throughout the GCL
(Figure 4A). Necrotic (FBDP-positive) cells, though,
were mainly detected in the outer layers of the GCL, in
differentiated neurons rather than immature NSPCs,
both 4 h and 24 h after HI (Figure 4). The total number
of dying cells was higher in Wt mice, particularly 24 h
after HI (Figure 4D). There were no AIF-positive cells,
displaying nuclear AIF, in Hq mice (Figure 4).
AIF downregulation reduced newborn cell death
Death of newly generated cells was detected by combining
BrdU staining with the cell death markers TUNEL or active
caspase-3 4 h and 24 h after HI (Figure 5A). The total num-
ber of TUNEL/BrdU double-positive cells in the SGZ was
2691±894 in the Wt mice and 731±186 (n=6) in the Hq
mice (n=7) (p=0.041) 4 h after HI. The total number of
active caspase-3/BrdU double-positive cells was also lower
in Hq mice (453±197) compared with Wt mice
(1229±304) (p=0.0498) (Figure 5B). In the Hq mice, fewer
cells were dying, but the overall numbers of BrdU-labeled
cells in the SGZ 4 h and 24 h after HI were not different be-
tween Hq and wild type mice, as shown above (Figure 2B).
The double-positive cells were fewer in the SGZ 4 h than
24 h after HI and no significant differences between Wt and
Hq mice were observed (data not shown).
AIF downregulation reduced pathological microglia
activation
The total numbers of microglia in the immature Wt or Hq
brains were not different, according to Iba-1 immunostain-
ing and quantification (Figure 6A, 6B). Galectin-3, a marker
of pathological microglia activation [29], was not detected
in the normal control brains, it was detected only in injured
areas, as expected (Figure 6A). The number of galectin-
3-positive cells was lower in the Hq mice than in Wt
mice after HI (Figure 6C). Some of the activated micro-
glia were observed engulfing dying cells, as judged by








































































Figure 3 Survival and differentiation of proliferated cells in the DG 4 weeks after HI. A. Representative microphotograph of BLBP staining in
the DG 4 weeks after HI. B. The bar graph shows quantification of the total number of BLBP-positive cells in the SGZ. C. Representative
microphotographs after BrdU staining in the DG at 4 weeks after HI. D. Quantification of BrdU-positive cells in the DG (GCL + SGZ) in the control
(Cont) and ipsilateral hemisphere after HI in Wt and Hq mice. E. Representative microphotograph showing triple labeling of BrdU/NeuN/S100 in
the DG. F. Quantification of the number of BrdU/NeuN double-positive cells (neurons) in DG (GCL) in the control (Cont) and ipsilateral hemisphere
after HI in Wt and Hq mice. * P< 0.05.
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Apoptosis is important during normal brain development
[30,31]. Our previous studies have shown that apoptotic
cell death after HI in the immature brain involves caspase-
dependent and –independent pathways [14]. Caspases are
activated after HI, particularly in the immature brain [12]
and caspase inhibition affords neuroprotection in the im-
mature brain [14,15,32]. A causal role of AIF for neuronal
cell death and brain injury following HI in the immature
brain has been identified by using Hq mutant mice, where
brain injury was reduced by 52.6% at 3 days after HI [14].
In this study we demonstrate long-term neuroprotection
in AIF-deficient mice after HI, where brain injury was
reduced by as much as 63.5% 4 weeks after HI. This
extends our earlier findings and further confirms that AIF
plays a major role in the development of brain injury afterHI. After HI, a large proportion of the dying neurons in
the immature brain are immunopositive for both active
caspase-3 and nuclear AIF, but there are also populations
of neurons displaying only active caspase-3 or only nuclear
AIF [18]. We found that Hq mice displayed approximately
50% smaller infarct volumes than wild type mice. The cas-
pase inhibitor Q-VD-OPh also produced approximately
50% smaller infarct volumes, and combining the two, by
treating Hq mice with Q-VD-OPh, produced an additional
50% infarct volume reduction [14]. Also in a model of
traumatic brain injury in adult mice, increased protection
was found when combining functional AIF reduction (as
in cyclophilin A −/− mice) with caspase inhibition (boc-
Asp-FMK) [33]. Hence, caspase-dependent and caspase-
independent (AIF-dependent) pathways appear to act, at





































































Figure 4 Cell death in the DG after HI. A. Representative stainings of active caspase-3, FBDP and AIF in the DG of Wt (left panel) and Hq (right
panel) mice 4 h after HI. B. The bar graph shows the quantification of positive cells for each cell death-related marker in the GCL at 4 h after HI. C.
Representative stainings of active caspase-3, FBDP and AIF in the DG of Wt (left panel) and Hq (right panel) mice 24 h after HI. D. The bar graph
shows the quantification of positive cells for each cell death-related marker in the GCL at 24 h after HI * P< 0.05, *** P< 0.001.
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released from mitochondria, AIF, as a flavoprotein, is es-
sential for the maintenance of a fully functional complex I
[34]. In healthy cells, the physiological role of AIF in sus-
taining complex I-driven oxidative phosphorylation appears
related to the local redox activity of AIF and is independent
of its proapoptotic properties [35]. Efforts to study the
mitochondrial function of AIF have focused on the putative
ability of AIF to regulate reactive oxygen species [36]. Gen-
etic mutant Hq mice with up to 80% reduction of mito-
chondrial AIF, display reduced levels of complex I and
impaired assembly of complex I subunits [37]. These mice
exhibit mitochondrial respiratory chain diseases, such as
cerebellar neurodegeneration with ataxia and progressive
retinal degeneration. A recent study showed that the mito-
chondrial complex I contributes to oxidative injury during
early reperfusion after HI in the neonatal mouse brain and
that inhibition of complex I decreased the extent of HI in-
jury [38]. The Hq mutation, displaying reduced levels of
AIF, but also reduced levels of for example catalase and
complex I, renders the brain tissue more susceptible to oxi-
dative stress [14,37]. We did not assess the levels of oxida-
tive stress in the SGZ in this study, but it would be
interesting to evaluate the effects of an antioxidant agent,
to see if the effects in the SGZ would be different from the
effects in mature neurons.Interestingly, we observed a wave of apoptotic cell
death starting at the inner layers of the GCL and mov-
ing outwards, and at the same time increasing about
10-fold in numbers of dying cells from 4 h to 24 h after
HI (Figure 4). Necrotic cell death, as judged by massive
calcium influx leading to calpain-specific cleavage of
fodrin to yield the 150 kDa breakdown product (FBDP),
was only observed in the outer layers of the GCL, indi-
cating that necrosis occurred only in fully differentiated
neurons, not in stem and progenitor cells. Only a frac-
tion of the BrdU-labeled cells in the inner layers of the
GCL died (underwent apoptosis) after HI. This means
that out of all the BrdU-labeled cells in the SGZ, born 1
or 2 days earlier and surviving until 4 h after HI, ap-
proximately 16% were TUNEL-positive and 7% were ac-
tive caspase-3-positive (compare Figures 2B and 5B). In
the Hq mice, approximately 70% fewer cells were dying
(were TUNEL-positive) in the SGZ after HI, but the
overall numbers of BrdU-labeled cells (dying and not
dying) in the SGZ 4 h and 24 h after HI were not differ-
ent between Hq and wild type mice (Figure 2B). The
double-positive cells were fewer in the SGZ 24 h than
4 h after HI and no significant differences between Wt
and Hq mice were observed (data not shown). As noted
above, by this time point (24 h) the wave of cell death




































Figure 5 Double labeling of BrdU and cell death markers after
HI. A. Representative double labelings of BrdU with the cell
death-related markers TUNEL and active caspase-3 in the DG 4 h and 24 h
after HI. B. The number of dying newborn cells in the SGZ, as indicated by
double labeling 4 h after HI, was lower in the Hq mice. * P< 0.05.
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layers (SGZ), even though the total number of dying
cells was approximately 10 times higher in the entire
GCL at this later time point. It is not clear why the ap-
parently lower rate of dying cells in the SGZ in Hq mice
did not lead to a difference in undifferentiated, BLBP-
positive cells 4 weeks later (Figure 2A, 2B). Presumably,
the AIF downregulation only protected neuronally com-
mitted progenitor cells and neurons, not undifferenti-
ated stem cells. Also, as mentioned above, it was only a
fraction of the BrdU-labeled cells that were TUNEL- or
active caspase-3-positive, and only a fraction of these
that was protected by the AIF deficiency. Nevertheless,
the loss of a number of undifferentiated as well as more
or less differentiated cells after HI leads to impaired
growth of the DG, resulting in a smaller DG volume
5 weeks after HI, as shown earlier [39]. Overall, we have
shown that AIF plays an important role not only in the
HI-induced death of mature neurons throughout the
brain, but also in the HI-induced death of newborn cells
and neuronal progenitors in the DG.
Neurogenesis can be induced by brain ischemia, indi-
cating that regenerative mechanisms are activated by in-
jurious stimuli. This could inspire hope for development
of restorative therapies for neurological disorders and
brain injuries. However, the majority of newborn cells
appearing after HI do not survive beyond 3 weeks, as
judged by BrdU-labeling [26,27]. Since immature cells
are more prone to undergo apoptosis than fully differen-
tiated neurons, particularly in the immature brain, we
propose that the continuous and massive decrease in
the number of BrdU-labeled cells induced by an injury
may be due to apoptosis-mediated cell death, which in
turn reduces the restorative capacity. A previous study
showed that stem and progenitor cells in the subventri-
cular zone die after HI at least partly through caspase-3
and calpain activation [6]. Under normal conditions in
the adult hippocampus, the majority of newborn cells
undergo death by apoptosis in the first 1 to 4 days of
life, during the transition from amplifying neuroprogeni-
tors to neuroblasts [40]. In the present study, we fol-
lowed the fate of cells born 1 or 2 days before HI, i.e.
when they were changing from transient amplifying cells
to neuroblasts. Reducing apoptosis through overexpres-
sion of bcl-2 under the neuron-specific enolase (NSE)
promoter was found to double the rate of neurogenesis
in the dentate gyrus as demonstrated by quantification
of doublecortin-positive progenitor cells and BrdU/
NeuN double-labeling. The effect of Bcl-2 was limited
to the late phase of progenitor maturation, presumably
correlating with the onset of NSE expression, as prolif-
eration and early-phase progenitor cells were not
affected and the increased level of neurogenesis led to a
























































Figure 6 Microglia activation after HI. A. Representative Iba-1 (upper panel) and galectin-3 (lower panel) immunostainings in the cortex of both
Wt and Hq control brains and 24 h after HI. B. Quantification of Iba-1-positive cells in the cortex did not show any difference between Wt and Hq
mice. C. Quantification of galectin-3-positive cells in the cortex 24 h after HI showed fewer pathologically activated microglia in the Hq mice. D. Triple
labeling with TUNEL, BrdU and Iba-1 or galectin-3 24 h after HI showing Iba-1- or galectin-3-positive cells engulfing dead cells (TUNEL-positive
chromatin fragments).
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could increase the number of surviving, seizure-induced
newborn neurons [42]. The role of AIF in the death of
newborn cells after HI in the immature brain has not
been investigated before. In this study, we found evi-
dence for AIF-induced cell death both in the early phase
of transient amplifying cells/early neuroblasts as well as
in the later phase of mature neuronal progenitors and
young neurons.
Conclusions
In summary, this study demonstrates that AIF plays a
role in the wave of apoptotic cell death extending from
the inner layers of the GCL outward and that downregu-
lation of AIF could rescue hippocampal neurogenesis.Materials and methods
Induction of HI brain injury
Postnatal day 10 (P10) wild type or Harlequin mutant
(Hq) mouse pups were anesthetized with isoflurane (5%
for induction, 1.5-3.0% for maintenance) in a mixture of
nitrous oxide and oxygen (1:1); the duration of anesthesia
was less than 5 min. The left common carotid artery was
cut between double ligatures of prolene sutures (6.0). After
the surgical procedures the wounds were infiltrated with
lidocaine for analgesia. The pups were returned to their
dams for 60 min and then placed in a chamber perfused
with a humidified gas mixture (10% oxygen in nitrogen)
for 45 min at 36°C to induce a mild brain injury [12]. Fol-
lowing hypoxic exposure, the pups were returned to their
dams until sacrifice. Control pups were neither subjected
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approved by the Gothenburg Committee of the Swedish
Animal Welfare Agency (145–2008).
BrdU administration
The thymidine analog 5-bromo-2-deoxyuridine (BrdU)
(Roche, Mannheim, Germany, 5 mg/mL dissolved in
0.9% saline) was prepared freshly prior to use and
injected intraperitoneally (50 mg/kg) on P8 and P9,
before HI (Figure 1A).
Injury evaluation
Brain injury was evaluated by the volume of total hemi-
spheric tissue loss, as judged by MAP2 immunostaining.
The MAP2-positive and -negative areas in each section
were measured using Micro Image (Olympus, Japan). The
tissue volume was calculated from the MAP2-positive areas
according to the Cavalieri principle using the following for-
mula: V=ΣA×P×T, where V= total volume, ΣA=sum of
area measurements, P= the inverse of the sampling fraction,
and T= the section thickness. The total hemispheric tissue
loss was calculated as the MAP2-positive volume in the
contralateral hemisphere minus the MAP2-positive volume
in the ipsilateral hemisphere.
Immunohistochemistry
The animals were anesthetized and perfusion-fixed with 5%
formaldehyde in 0.1 M PBS. The paraffin-embedded brains
were serial cut in 5 μm coronal sections and mounted on
glass slides. On the hippocampus level, every 50th section
was stained. Antigen retrieval was performed by heating the
sections in 10 mM boiling sodium citrate buffer (pH 6.0)
for 10 min. Nonspecific binding was blocked for 30 min
with 4% goat or horse or donkey serum in PBS. Monoclonal
rat anti-BrdU (1:100, 5 μg/ml; clone: BU1/75, Oxford Bio-
technology Ltd. Oxfordshire, UK), monoclonal mouse anti-
MAP-2 (1:1000, clone HM-2, Sigma, Saint Louis, Missouri,
USA), rabbit anti-active caspase-3 (1:100, 10 μg/ml, BD
Pharmingen, USA), rabbit anti-FBDP (1:50), goat anti-AIF
(1:100, 2 μg/ml, sc-9416, Santa Cruz), rabbit anti-brain lipid
binding protein (BLBP) (1:600, ABN14, Millipore, Teme-
cula, CA, USA), rabbit anti-Iba-1 (1:1000, 0.5 μg/ml, Wako,
Osaka, Japan), rat anti-galectin-3 (1:100, 5 μg/ml,
eBioscience, San Diego, CA, USA) primary antibody was
applied and incubated at 20°C for 60 min, followed by the
appropriate biotinylated secondary antibodies for 60 min at
20°C. Visualization was performed using Vectastain ABC
Elite kit (Vector Laboratories, Burlingame, CA, USA).
For TUNEL and BrdU double or triple labelings, after
antigen retrieval, sections were incubated with 3% bovine
serum albumin in 0.1 M Tris–HCl (pH 7.5) for 30 min
followed by 50 μl of TUNEL reaction mixture on each
sample for 60 min at 37°C in a moisture chamber. After
washing, the sections were incubated with rat anti-BrdU(1:100, 5 μg/ml; clone: BU1/75, Oxford Biotechnology
Ltd. Oxfordshire, UK) or mouse anti-BrdU and rabbit
anti-Iba-1 or mouse anti-BrdU and rat anti-galectin-3 for
60 min at room temperature. After washing, the sections
were incubated appropriate Alexa Fluor labeled donkey
anti-rat IgG (H+L) or Alexa Fluor 555 donkey anti-
rabbit and Alexa Fluor 647 donkey anti-mouse or Alexa
Fluor 555 donkey anti-rat and Alexa Fluor 647 donkey
anti-mouse at 20°C for 60 min. For active caspase-3 and
BrdU double labeling, rabbit anti-active caspase-3(1:100,
10 μg/ml, BD Pharmingen, USA) and rat anti-BrdU
(1:100, 1:100, 5 μg/ml) were incubated at 20°C for
60 min. After washing, the sections were incubated with
Alexa Fluor 555 donkey anti-rat IgG (H+L), combined
with Alexa 488 donkey anti-rabbit IgG (H+L).
The phenotype of BrdU-labeled cells was determined
using antibodies against NeuN or S100β. The sections
were incubated with rat anti-BrdU together with mouse
anti-NeuN monoclonal antibody (1:200, 5 μg/ml; clone:
MAB377, Chemicon, Temecula, CA, USA) and rabbit
anti-S-100ß (1:1000; Swant, Bellinzona, Switzerland) in
PBS at 20°C for 60 min. After washing, the sections were
incubated with secondary antibodies, Alexa Fluor 488 don-
key anti-rat IgG (H+L), combined with Alexa 555 donkey
anti-mouse IgG (H+L) and Alexa 647 donkey anti-rabbit
IgG (H+L) at 20°C for 60 min. All secondary antibodies
were from Jackson ImmunoResearch Lab and were diluted
1:500. After washing, the sections were mounted using
Vectashield mounting medium.
Cell counting
The number of BrdU-labeled cells were counted in every
50th section in the subgranular zone (SGZ) 4 h or 24 h
after HI, or in the entire granule cell layer (GCL), in-
cluding the SGZ, 4 weeks after HI, using unbiased
stereological counting techniques (StereoInvestigator,
MicroBrightField Inc., Magdeburg, Germany). For the
phenotype, at least 50 BrdU-positive cells in the GCL were
phenotyped using a confocal laser scanning microscope
(Leica TCS SP, Heidelberg, Germany) and the ratio of Brdu/
NeuN or BrdU/S100β double-labeled cells was calculated
for each sample. The total number of neurons (BrdU/
NeuN-positive) and astrocytes (BrdU/S100β-positive) in
each sample was calculated based on the number of BrdU-
positive cells and the ratio of double labeling. The BrdU
and TUNEL or BrdU and active caspase-3 double-positive
cells were counted in the SGZ by using confocal micros-
copy. The Iba-1- or galectin-3-positive cells were counted
at 400x magnification in the border zone of the injured cor-
tex within an area of 0.196 mm2. Three sections were
counted from each brain with an interval of 250 μm. The
average was used as n=1 when comparing different brains.
All the counting was carried out by investigators blinded to
group assignment.
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All data are expressed as mean ± s.e.m. Student’s un-
paired t-test was used to compare the numbers of cell
death-related markers, BrdU-positive cell numbers, num-
bers of newborn neurons and astrocytes between the two
groups. Significance was assumed when p< 0.05.
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